InfiCure Bio at Umeå Life Science Job Fair!
Today on May 3rd, Umeå Biotech Incubator (UBI) organized the first Umeå Life Science Job Fair. We at InfiCure Bio were happy to get the opportunity to present our business to life science students and [...]
Pressrelease published on the CymaBay Seladelpar study!
Take the opportunity to read the pressrelease on the CymaBay study with Seladelpar in the NIF mouse. Ed Cable, sr. Director of Research at CymaBay Therapeutics, gives his view on why CymaBay chose to work [...]
Check out CymaBay Therapeutics poster on the NIF mouse at AASLD!
We are very happy that CymaBay Therapeutics chose to present the convincing data from their study in the NIF mouse. They nicely show that Seladelpar, which is a substance in clinical studies, reduces fibrosis in [...]
The NIF mouse in Cyma Bay preclinical study using Seladelpar
We are happy and proud that our NIF mouse is the model used in the preclinical poster presented by Cymabay Therapeutics at the upcoming AASLD meeting, with the title "Seladelpar reduces established liver and renal [...]
Take a look at InfiCures poster from the EASL NAFLD Summit!
InfiCure Bio attended the EASL NAFLD Summit in September, and presented this poster with up-to-date data on the NIF mouse.